Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18942162 | METHOD OF SEQUENCING A NUCLEIC ACID OF INTEREST | November 2024 | June 2025 | Allow | 7 | 2 | 0 | Yes | No |
| 18594336 | METHODS FOR MONITORING RESIDUAL DISEASE | March 2024 | July 2024 | Allow | 4 | 1 | 0 | No | No |
| 18588765 | METHODS OF AMPLIFYING CIRCULAR POLYNUCLEOTIDES IN SITU | February 2024 | August 2024 | Allow | 6 | 2 | 0 | No | No |
| 18538986 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | December 2023 | August 2024 | Allow | 8 | 1 | 0 | No | No |
| 18535485 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | December 2023 | April 2024 | Allow | 4 | 1 | 0 | No | No |
| 18520939 | DNA Methylation Analysis to Identify Cell Type | November 2023 | June 2024 | Allow | 6 | 1 | 0 | No | No |
| 18491071 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | October 2023 | April 2024 | Allow | 6 | 1 | 0 | No | No |
| 18236540 | PROBE-BASED ANALYSIS OF NUCLEIC ACIDS AND PROTEINS | August 2023 | January 2024 | Allow | 5 | 1 | 0 | No | No |
| 18448618 | METHODS FOR IDENTIFYING A LOCATION OF AN RNA IN A BIOLOGICAL SAMPLE | August 2023 | February 2024 | Allow | 6 | 2 | 0 | No | No |
| 18226933 | METHODS, COMPOSITIONS, AND KITS FOR BLOCKING A CAPTURE PROBE ON A SPATIAL ARRAY | July 2023 | October 2023 | Allow | 3 | 1 | 0 | No | No |
| 18219545 | METHODS FOR ANALYZING BIOLOGICAL SAMPLES IN A FLUIDIC DEVICE COMPRISING GENERATING A POLYMER MATRIX FROM PRECURSORS AT DISCRETE AREAS | July 2023 | January 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18333436 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | June 2023 | September 2023 | Allow | 3 | 1 | 0 | No | No |
| 18317550 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | May 2023 | August 2024 | Allow | 15 | 1 | 0 | No | No |
| 18316870 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | May 2023 | May 2024 | Allow | 12 | 1 | 0 | Yes | No |
| 18316864 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | May 2023 | August 2023 | Allow | 4 | 1 | 0 | No | No |
| 18307666 | FETAL SEX DETERMINATION USING CAPILLARY BLOOD FROM UPPER ARM | April 2023 | January 2024 | Allow | 9 | 2 | 0 | No | No |
| 18123235 | Method for the Analysis of Minimal Residual Disease | March 2023 | August 2023 | Allow | 5 | 1 | 0 | Yes | No |
| 18186015 | METHODS FOR MULTIPLEX DETECTION OF POLYNUCLEOTIDES USING UNBOUND FLUORESCENT PROBES AND QUENCHER OLIGONUCLEOTIDES | March 2023 | January 2024 | Allow | 10 | 1 | 1 | Yes | No |
| 18181263 | METHODS, COMPOSITIONS, AND KITS FOR BLOCKING A CAPTURE PROBE ON A SPATIAL ARRAY | March 2023 | July 2023 | Allow | 4 | 1 | 0 | No | No |
| 18176616 | NUCLEIC ACID CIRCULARIZATION AND AMPLIFICATION ON A SURFACE | March 2023 | May 2024 | Allow | 14 | 2 | 0 | Yes | No |
| 18166429 | COMPOSITIONS AND METHODS FOR PAIRWISE SEQUENCING | February 2023 | August 2023 | Allow | 6 | 1 | 0 | No | No |
| 18157249 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | January 2023 | August 2023 | Allow | 7 | 2 | 0 | No | No |
| 18061898 | METHODS AND SYSTEMS FOR ANALYZING NUCLEIC ACID MOLECULES | December 2022 | December 2023 | Allow | 12 | 1 | 0 | Yes | No |
| 17997174 | DEVICES AND METHODS FOR MULTI-DIMENSIONAL GENOME ANALYSIS | October 2022 | July 2023 | Allow | 9 | 1 | 0 | No | No |
| 17947984 | METHODS AND REAGENTS FOR NUCLEIC ACID ANALYSIS | September 2022 | May 2023 | Allow | 8 | 1 | 0 | Yes | No |
| 17822117 | METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES | August 2022 | May 2024 | Allow | 21 | 1 | 0 | No | No |
| 17890208 | UNIVERSAL SHORT ADAPTERS WITH VARIABLE LENGTH NON-RANDOM UNIQUE MOLECULAR IDENTIFIERS | August 2022 | September 2023 | Allow | 13 | 1 | 0 | No | No |
| 17814062 | METHODS AND COMPOSITIONS FOR SEQUENCING DOUBLE STRANDED NUCLEIC ACIDS USING RCA AND MDA | July 2022 | January 2023 | Allow | 6 | 0 | 0 | Yes | No |
| 17869595 | METHODS, COMPOSITIONS, AND KITS FOR PREPARING NUCLEIC ACID LIBRARIES | July 2022 | February 2024 | Allow | 19 | 0 | 0 | No | No |
| 17812380 | COMPOSITIONS AND METHODS FOR RAPID IDENTIFICATION AND PHENOTYPIC ANTIMICROBIAL SUSCEPTIBILITY TESTING OF BACTERIA AND FUNGI | July 2022 | January 2024 | Allow | 18 | 1 | 0 | No | No |
| 17810696 | CHROMOPHORE-BASED DETECTION OF GENETIC VARIATIONS IN ANALYTES | July 2022 | September 2023 | Allow | 14 | 1 | 0 | No | No |
| 17810103 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | June 2022 | November 2022 | Allow | 5 | 1 | 0 | No | No |
| 17809544 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | June 2022 | November 2022 | Allow | 5 | 1 | 0 | No | No |
| 17825669 | METHOD OF DETECTING AND QUANTIFYING GENOMIC AND GENE EXPRESSION ALTERATIONS USING RNA | May 2022 | March 2023 | Allow | 10 | 1 | 1 | No | No |
| 17738979 | DEVICES AND METHODS FOR ANTIBIOTIC SUSCEPTABILITY TESTING | May 2022 | November 2023 | Allow | 18 | 1 | 0 | No | No |
| 17719214 | METHODS OF SEQUENCING CIRCULAR TEMPLATE POLYNUCLEOTIDES | April 2022 | September 2022 | Allow | 5 | 1 | 0 | Yes | No |
| 17708981 | MATERIALS AND METHODS FOR LOCALIZED DETECTION OF NUCLEIC ACIDS IN A TISSUE SAMPLE | March 2022 | March 2023 | Allow | 11 | 1 | 0 | Yes | No |
| 17708169 | LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) BASED ASSAY FOR DETECTING MICROBES | March 2022 | March 2024 | Allow | 23 | 2 | 0 | Yes | No |
| 17696524 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | March 2022 | December 2022 | Allow | 9 | 2 | 0 | No | No |
| 17685964 | HIGHLY SENSITIVE METHODS FOR ACCURATE PARALLEL QUANTIFICATION OF NUCLEIC ACIDS | March 2022 | July 2022 | Allow | 4 | 1 | 0 | No | No |
| 17637432 | METHOD FOR THE GENERATION OF DUMBBELL-SHAPED DNA VECTORS | February 2022 | June 2024 | Allow | 28 | 1 | 0 | No | No |
| 17588089 | DIAGNOSIS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE | January 2022 | May 2024 | Allow | 28 | 1 | 1 | Yes | No |
| 17581285 | Integrated Device For Nucleic Acid Detection And Identification | January 2022 | January 2024 | Allow | 24 | 2 | 0 | Yes | No |
| 17578296 | METHODS FOR INTERNALLY CONTROLLED IN SITU ASSAYS USING PADLOCK PROBES | January 2022 | April 2024 | Allow | 27 | 0 | 0 | No | No |
| 17571360 | Sequencing Methods Using Improved Nucleotide Reagent Solutions | January 2022 | August 2023 | Allow | 20 | 1 | 0 | No | No |
| 17563781 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | December 2021 | July 2022 | Allow | 7 | 1 | 0 | No | No |
| 17563816 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | December 2021 | February 2023 | Allow | 13 | 3 | 0 | Yes | No |
| 17558534 | METHODS AND SYSTEMS FOR DETECTING USUAL INTERSTITIAL PNEUMONIA | December 2021 | September 2023 | Allow | 21 | 4 | 0 | Yes | No |
| 17543944 | RNA ISOLATION FROM SOLUBLE URINE FRACTIONS | December 2021 | December 2023 | Allow | 24 | 2 | 0 | No | No |
| 17530813 | METHODS FOR MULTIPLEX PCR | November 2021 | April 2024 | Abandon | 29 | 1 | 0 | Yes | No |
| 17526638 | ISOLATED OLIGONUCLEOTIDES CONTAINING MODIFIED NUCLEOTIDES | November 2021 | September 2023 | Allow | 22 | 1 | 0 | No | No |
| 17522741 | METHODS FOR PROCESSING NUCLEIC ACID SAMPLES | November 2021 | February 2024 | Abandon | 27 | 1 | 0 | No | No |
| 17521239 | COMPOSITIONS AND METHODS FOR PAIRWISE SEQUENCING | November 2021 | November 2023 | Allow | 24 | 1 | 0 | No | No |
| 17513213 | PROCESS FOR THE ENZYMATIC SYNTHESIS AND AMPLIFICATION OF NUCLEIC ACIDS | October 2021 | December 2023 | Abandon | 25 | 1 | 0 | No | No |
| 17512587 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | October 2021 | August 2023 | Allow | 21 | 1 | 0 | No | No |
| 17512581 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | October 2021 | August 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17507373 | METHODS FOR ISOLATION OF CELL-FREE DNA USING AN ANTI-DOUBLE-STRANDED DNA ANTIBODY | October 2021 | January 2023 | Allow | 15 | 2 | 1 | No | No |
| 17497230 | SYSTEMS AND METHODS FOR COMBINED DETECTION OF GENETIC ALTERATIONS | October 2021 | October 2023 | Allow | 24 | 1 | 0 | No | No |
| 17600826 | DNA PROTECTION AGENT IN DNA IMAGING BUFFER | October 2021 | May 2023 | Allow | 19 | 1 | 0 | No | No |
| 17473760 | METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES | September 2021 | April 2024 | Allow | 31 | 1 | 0 | No | No |
| 17458162 | SELECTIVE AMPLIFICATION OF OVERLAPPING AMPLICONS | August 2021 | October 2023 | Allow | 26 | 1 | 0 | No | No |
| 17410903 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | August 2021 | March 2022 | Allow | 7 | 1 | 0 | No | No |
| 17407945 | SINGLE CELL SEQUENCING | August 2021 | June 2023 | Allow | 21 | 1 | 0 | No | No |
| 17403537 | DETECTION OF GENE FUSIONS BY INTRAGENIC DIFFERENTIAL EXPRESSION (IDE) USING AVERAGE CYCLE THRESHOLDS | August 2021 | October 2023 | Allow | 26 | 2 | 0 | No | No |
| 17396171 | METHODS FOR HIGH LEVEL MULTIPLEXED POLYMERASE CHAIN REACTIONS AND HOMOGENEOUS MASS EXTENSION REACTIONS | August 2021 | July 2023 | Allow | 23 | 1 | 0 | No | No |
| 17386338 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | July 2021 | February 2022 | Allow | 7 | 1 | 0 | No | No |
| 17377284 | COMPOSITIONS AND METHODS FOR PAIRWISE SEQUENCING | July 2021 | October 2021 | Allow | 3 | 1 | 0 | Yes | No |
| 17370836 | MUTATION DETECTION ASSAY | July 2021 | August 2023 | Allow | 25 | 1 | 0 | No | No |
| 17370941 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | July 2021 | February 2022 | Allow | 7 | 1 | 0 | No | No |
| 17368276 | METHODS FOR IDENTIFYING A LOCATION OF AN RNA IN A BIOLOGICAL SAMPLE | July 2021 | July 2023 | Allow | 25 | 1 | 0 | No | No |
| 17312998 | METHOD OF NUCLEIC ACID ENRICHMENT USING SITE-SPECIFIC NUCLEASES FOLLOWED BY CAPTURE | June 2021 | June 2022 | Allow | 12 | 1 | 0 | No | No |
| 17300304 | METHOD OF ANALYZING NUCLEIC ACID TEMPLATES USING RAPID LAMP | May 2021 | September 2023 | Abandon | 28 | 1 | 0 | No | No |
| 17329844 | MULTIPLE AMPLIFICATION CYCLE DETECTION | May 2021 | December 2023 | Allow | 30 | 2 | 0 | No | No |
| 17326844 | Compositions Including A Double Stranded Nucleic Acid Molecule And A Stem-Loop Oligonucleotide | May 2021 | September 2023 | Abandon | 28 | 2 | 0 | No | No |
| 17244000 | METHODS FOR FAST NUCLEIC ACID AMPLIFICATION | April 2021 | July 2023 | Allow | 27 | 1 | 0 | No | No |
| 17238016 | METHODS FOR MULTIPLEX PCR | April 2021 | October 2021 | Allow | 5 | 1 | 0 | No | No |
| 17302030 | TCR/BCR Profiling Using Enrichment With Pools of Capture Probes | April 2021 | March 2022 | Allow | 11 | 1 | 0 | No | No |
| 17236743 | DROPLET TAGGING CONTIGUITY PRESERVED TAGMENTED DNA | April 2021 | February 2023 | Allow | 22 | 1 | 0 | No | No |
| 17225659 | THREE-DIMENSIONAL SPATIAL MOLECULAR INDEXING | April 2021 | June 2024 | Allow | 38 | 1 | 0 | No | No |
| 17225597 | COMPOSITION FOR IMPROVING MOLECULAR BARCODING EFFICIENCY AND USE THEREOF | April 2021 | September 2023 | Allow | 29 | 1 | 0 | No | No |
| 17223565 | Methods and Systems for Detecting Biological Components | April 2021 | September 2023 | Allow | 29 | 2 | 0 | No | No |
| 17223718 | PURIFICATION OF NUCLEIC ACIDS USING COPPER-TITANIUM OXIDES | April 2021 | November 2022 | Allow | 19 | 1 | 0 | No | No |
| 17209957 | DIRECT QUANTIFICATION OF UNPROCESSED NUCLEIC ACID SAMPLES | March 2021 | January 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17209229 | IMMUNE PROFILING USING SMALL VOLUME BLOOD SAMPLES | March 2021 | April 2023 | Allow | 24 | 1 | 1 | No | No |
| 17209602 | PCR REACTION VESSEL, PCR DEVICE, AND PCR METHOD | March 2021 | July 2023 | Allow | 28 | 1 | 0 | No | No |
| 17210191 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | March 2021 | February 2024 | Allow | 35 | 2 | 0 | No | No |
| 17208538 | METHODS FOR NEXT GENERATION GENOME WALKING AND RELATED COMPOSITIONS AND KITS | March 2021 | June 2023 | Allow | 27 | 1 | 1 | Yes | No |
| 17271215 | SET OF GENES FOR MOLECULAR CLASSIFYING OF MEDULLOBLASTOMA AND USE THEREOF | February 2021 | January 2022 | Allow | 11 | 2 | 0 | Yes | No |
| 17267810 | SET OF GENES FOR BLADDER CANCER DETECTION AND USE THEREOF | February 2021 | March 2022 | Allow | 14 | 3 | 0 | Yes | No |
| 17169609 | METHODS FOR CHARACTERIZING DNA SEQUENCE COMPOSITION IN A GENOME | February 2021 | February 2023 | Allow | 24 | 1 | 0 | No | No |
| 17167974 | METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS | February 2021 | July 2021 | Allow | 5 | 1 | 0 | No | No |
| 17152529 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | January 2021 | March 2021 | Allow | 2 | 1 | 0 | No | No |
| 17147826 | BEAD BEATING TUBE AND METHOD FOR EXTRACTING DEOXYRIBONUCLEIC ACID AND/OR RIBONUCLEIC ACID FROM MICROORGANISMS | January 2021 | December 2023 | Allow | 35 | 1 | 1 | No | No |
| 17146986 | SINGLE CELL SEQUENCING | January 2021 | July 2021 | Allow | 6 | 2 | 0 | No | No |
| 17146359 | SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION | January 2021 | March 2021 | Allow | 2 | 1 | 0 | No | No |
| 17140640 | METHOD FOR DETECTING ON-TARGET AND PREDICTED OFF-TARGET GENOME EDITING EVENTS | January 2021 | October 2023 | Allow | 33 | 2 | 0 | No | No |
| 17139451 | DEVICES AND METHODS FOR ANTIBIOTIC SUSCEPTABILITY TESTING | December 2020 | November 2021 | Allow | 11 | 1 | 1 | Yes | No |
| 17251923 | METHOD FOR DISCRIMINATING BETWEEN LIVE AND DEAD MICROBES IN A SAMPLE | December 2020 | January 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17251451 | LINEAGE TRACING USING MITOCHONDRIAL GENOME MUTATIONS AND SINGLE CELL GENOMICS | December 2020 | February 2024 | Allow | 38 | 1 | 0 | No | No |
| 16973990 | METHOD AND DEVICE FOR DIGITAL PCR MEASUREMENT | December 2020 | February 2024 | Allow | 38 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HORLICK, KENNETH R.
With a 23.1% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 20.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner HORLICK, KENNETH R works in Art Unit 1637 and has examined 1,015 patent applications in our dataset. With an allowance rate of 69.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 29 months.
Examiner HORLICK, KENNETH R's allowance rate of 69.1% places them in the 23% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by HORLICK, KENNETH R receive 1.61 office actions before reaching final disposition. This places the examiner in the 43% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by HORLICK, KENNETH R is 29 months. This places the examiner in the 44% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +29.0% benefit to allowance rate for applications examined by HORLICK, KENNETH R. This interview benefit is in the 80% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 26.3% of applications are subsequently allowed. This success rate is in the 33% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 57.1% of cases where such amendments are filed. This entry rate is in the 79% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 48.0% of appeals filed. This is in the 10% percentile among all examiners. Of these withdrawals, 58.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 36.7% are granted (fully or in part). This grant rate is in the 33% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 5.5% of allowed cases (in the 90% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.3% of allowed cases (in the 46% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.